IP Library › Granted Patent US 12,022,829
Granted Patent B2
US 12,022,829 · App. 17/278,839 · Granted Jul 2, 2024

Water-dispersible fine particle

Inventor: Hirofumi Hakuba (Shiga, JP)
Assignee: TOYOBO CO., LTD.
A01N37/46
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,022,829
App. No.
17/278,839
Granted
Jul 2, 2024
Kind
B2
Abstract

The objective of the present invention is to provide a material to inhibit and/or remove a formation of a biofilm which material can be dispersed in water, of which effect can be sustained even in an environment such as water section, and which is highly safe and environmentally friendly. [Solution] The present invention relates to a fine particle comprising a complex consisting of a polycarboxylic acid derivative and a drug, wherein the fine particle is water-dispersible.

Claims (15)

1. A particle comprising a complex consisting of a polycarboxylic acid derivative and a drug,

wherein the polycarboxylic acid derivative is a compound produced by condensing a polycarboxylic acid and a propargyl amino acid represented by the following formula (1):

wherein

R is a hydrogen atom or a C 1-8 hydrocarbon group,

a plurality of hydrogen atoms in the hydrocarbon group may be substituted by a nitrogen atom, an oxygen atom, or a sulfur atom, and

n is an integer between 1 and 3, inclusive, and

wherein the particle is water-dispersible.

2. The particle according to claim 1 , wherein the particle is an aggregate of the complex.

3. The particle according to claim 1 , wherein the drug comprises an antimicrobial peptide.

4. The particle according to claim 1 , wherein the drug comprises ε-poly-L-lysine.

5. The particle according to claim 1 , wherein the polycarboxylic acid is one or more selected from the group consisting of polyglutamic acid, polyacrylic acid, alginic acid and salts thereof.

6. The particle according to claim 1 , wherein an average particle size is between 0.05 μm and 0.7 μm, inclusive.

7. The fine particle according to claim 1 , wherein a molar ratio of the drug to the propargyl amino group of the polycarboxylic acid derivative is between 0.1 and 0.75, inclusive.

8. An antimicrobial agent and/or a biofilm remover comprising the particle according to claim 1 .

9. An antimicrobial agent and/or a biofilm remover comprising the particle according to claim 4 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2021
From: HAKUBA, HIROFUMI
To: TOYOBO CO., LTD.
Reel/Frame 055688/0716 →
Priority Claims (1)
JP 2018-178695 · Sep 25, 2018 · national
Continuity (1)
Related Publication 20220030861A1 · Feb 3, 2022